Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539720 · ClinicalTrials.gov registry record · NA
Levonorgestrel Intrauterine System For Emergency Contraception
A NA study, sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri.
- Completed
- Registry status
- NA
- Development phase
- 274
- Enrollment target
NCT01539720 is a NA study that has completed, run by Planned Parenthood of the St. Louis Region and Southwest Missouri. The registered enrollment target is 274 participants.
The verdict
NCT01539720, a NA study, has completed, sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri.
- COMPLETED
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.
Interventions
- DRUG Ulipristal acetate
- DEVICE levonorgestrel IUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2012-12 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01539720
The ClinicalTrials.gov registry entry for NCT01539720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood of the St. Louis Region and Southwest Missouri, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ulipristal acetate is the first listed.
NCT01539720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01539720 about?
NCT01539720 is a clinical study titled "Levonorgestrel Intrauterine System For Emergency Contraception". The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is...
What is the current status of trial NCT01539720?
This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2012-12. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT01539720?
The interventions under investigation include: Ulipristal acetate (DRUG), levonorgestrel IUS (DEVICE).
Who is sponsoring clinical trial NCT01539720?
This trial is sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.